Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$176
New position
Shares Held
5
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#489
of 494 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Seneschal Advisors, LLC holds $3,407 across 9 Biotechnology names. ROIV ranks #6 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2 | $993 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1 | $623 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2 | $602 | |
| 4 | INCY |
Incyte Corp
|
5 | $566 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1 | $187 | |
| 6 | ROIV |
Roivant Sciences Ltd.
This page
|
5 | $176 | |
| 7 | MRNA |
Moderna, Inc.
|
2 | $140 | |
| 8 | INSM |
INSMED Inc
|
1 | $106 |
All Filings in ROIV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $176 | 5 | Shares | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||